doc. MUDr. Regina Demlová, Ph.D.
Department head, Department of Pharmacology
office: bldg. A19/117
Kamenice 753/5
625 00 Brno
phone: | +420 549 49 6526, +420 725 828 385 |
---|---|
e‑mail: |
social and academic networks: |
---|
Total number of publications: 280
2017
-
Behaviorální účinky aripiprazolu ve vývojovém modelu schizofrenie
Year: 2017, type: Conference abstract
-
Immunomonitoring of patients treated with personalized dendritic cell-based vaccine
Year: 2017, type: Conference abstract
-
MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9
Oncogenesis, year: 2017, volume: 6, edition: 11, DOI
-
Nežádoucí metabolické účinky aripiprazolu v polyI:C modelu schizofrenie u potkana
Year: 2017, type: Appeared in Conference without Proceedings
-
Predictive value of quantitative HER2, HER3 and p95HER2 levels in HER2-positive advanced breast cancer patients treated with lapatinib following progression on trastuzumab
Oncotarget, year: 2017, volume: 8, edition: 61, DOI
-
The Cost Study of Cetuximab and Panitumumab in The First-Line Treatment of Mcrc in The Czech Republic
Year: 2017, type: Conference abstract
2016
-
18PTKI pazopanib impaires immunostimulatory properties of monocytes: Implication for monocyte-derived DC-based anti-cancer vaccine preparation
Year: 2016, type: Conference abstract
-
Immunohistochemical prediction of lapatinib efficacy in advanced HER2-positive breast cancer patients
Oncotarget, year: 2016, volume: 7, edition: 1, DOI
-
MicroRNA-Based Therapy in Animal Models of Selected Gastrointestinal Cancers
Frontiers in Pharmacology, year: 2016, volume: 7, edition: 329, DOI
-
MikroRNA-215 jako potenciální terapeutický cíl u kolorektálního karcinomu
Year: 2016, type: Conference abstract